Cubist Pharmaceuticals (CBST) to be Acquired by Merck in $9.5B Deal

Shares of Cubist Pharmaceuticals Inc. (CBST) were up +26.66 or +35.85 percent to $101.02 per share in this morning’s premarket, after news broke late Friday that the company was in acquisition talks with Merck & Co. MRK. The deal, which was just announced this morning, could be worth as much as $9.5 billion. Cubist stock Read the full article... Read the rest of Cubist Pharmaceuticals (CBST) to be Acquired by Merck in $9.5B Deal at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.